Dirk  Elston  to  Cost-Benefit Analysis
                            
                            
                                This is a "connection" page, showing publications  Dirk  Elston  has written about  Cost-Benefit Analysis.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.309
         
        
        
     
 
    
        
        - 
            Letter from the Editor: Cost-effectiveness of tuberculosis screening in patients already on biologic therapy. J Am Acad Dermatol. 2022 10; 87(4):747-748.
            
            
                Score: 0.167
             
- 
            Quality measures: do they really measure quality? Cutis. 2010 Jul; 86(1):8-10.
            
            
                Score: 0.073
             
- 
            Comparative effectiveness research: get to know the term. Cutis. 2009 Jun; 83(6):287-8.
            
            
                Score: 0.068